FDA warns Omicron and other variants may affect the performance of specific COVID-19 tests

Last Updated: Dec 10, 2021

Over the course of the COVID-19 pandemic, the SARS-CoV-2 virus has mutated over time, resulting in genetic variation in the population of circulating viral strains. Molecular, antigen, and serology tests are affected by viral mutations differently due to the inherent design differences of each test. Read More